Luxturna has become the first gene therapy to receive government funding in Australia, in a landmark decision that will see the treatment jointly funded by federal and state governments.
Read More
Sydney surgeon details first Luxturna gene therapy allowing patient to see stars
The vitreoretinal surgeon who performed Australia’s first Luxturna gene therapy has described the intricacy of the procedure, while hailing the team effort that has resulted in profound vision improvements for patients, including one who reported seeing stars for the first time.
Read More
Siblings treated with Luxturna gene therapy in Australian first (video included)
Teenage siblings from Sydney with an inherited retinal disease have become the first in Australia to receive the Luxturna ocular gene therapy. Those involved with delivering the novel treatment say it has rescued their vision, with hopes it will prevent them from going blind.
Read More
Read More
Building Australia’s gene therapy capability
The rapidly evolving field of gene therapy offers a unique opportunity for Australian eye surgeons and scientists to join forces and lead the world in preventing blindness.
Read More
Rewriting eye disease: Are we ready for gene therapies?
In 2020, ophthalmology became the first medical field in Australia to secure approval for a gene therapy. The one-off treatment can restore vision in people once resigned to a lifetime of blindness and is expected to pave the way for many more. MYLES HUME analyses the opportunities and challenges posed by ocular gene therapies.
Read More
Read More
Aussie IRD study taps into gene therapy perceptions
Researchers from the Centre for Eye Research Australia and University of Melbourne have developed a world-first survey to gather the views of Australians with inherited retinal diseases (IRDs) on potential gene therapies.
Read More
Read More
2020: a year like no other
Insight takes a look at the innovations, breakthroughs, setbacks, events and stories that shaped the Australian ophthalmic sector in 2020.
Read More
Read More
Race to identify inherited retinal disease patients for gene therapies
Australian researchers are using genetic testing to identify as many people as possible with inherited retinal disease (IRD), in preparation for an influx of life-changing gene and stem cell therapies expected over the next decade.
Read More
Read More
Reflections on a presidency
Two years has passed quickly and I will hand over to Associate Professor Nitin Verma on 10 October 2020.
Read More
Read More
TGA approves Luxturna gene therapy
In a historical development for the eye health sector, the Therapeutics Goods Administration (TGA) has approved the country’s first true gene therapy, indicated for a rare form of inherited retinal disease (IRD).
Read More
Read More